Tricol Biomedical, Inc.
Tricol Biomedical, Inc., headquartered in the United States, is a leading innovator in the biomedical industry, specialising in advanced medical devices and biopharmaceuticals. Founded in 2005, the company has established a strong presence in key operational regions across North America and Europe, focusing on enhancing patient care through cutting-edge technology. Tricol Biomedical is renowned for its unique product offerings, including innovative wound care solutions and regenerative medicine therapies that set new standards in efficacy and safety. With a commitment to research and development, the company has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. Tricol Biomedical continues to make strides in improving health outcomes, solidifying its reputation as a market leader in the biomedical field.
DitchCarbon Score
How does Tricol Biomedical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tricol Biomedical, Inc.'s score of 18 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tricol Biomedical, Inc.'s reported carbon emissions
Tricol Biomedical, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biomedical industry. As the sector increasingly focuses on sustainability, it is essential for companies like Tricol Biomedical to establish clear climate commitments and measurable targets to align with global efforts in reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tricol Biomedical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
